{"id":3256,"date":"2025-07-22T12:26:51","date_gmt":"2025-07-22T11:26:51","guid":{"rendered":"https:\/\/claretcapitaldev.alchemy.construction\/?p=3256"},"modified":"2025-09-17T17:29:22","modified_gmt":"2025-09-17T16:29:22","slug":"abivax-announces-positive-phase-3-results-from-both-abtect-8-week-induction-trials-investigating-obefazimod-its-first-in-class-oral-mir-124-enhancer-in-moderate-to-severely-active-ulcerative-colitis","status":"publish","type":"post","link":"https:\/\/www.claret-capital.com\/articles\/abivax-announces-positive-phase-3-results-from-both-abtect-8-week-induction-trials-investigating-obefazimod-its-first-in-class-oral-mir-124-enhancer-in-moderate-to-severely-active-ulcerative-colitis\/","title":{"rendered":"Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"class_list":["post-3256","post","type-post","status-publish","format-standard","hentry","category-uncategorised","media-type-allportfolio-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.claret-capital.com\/wp-json\/wp\/v2\/posts\/3256","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.claret-capital.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.claret-capital.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.claret-capital.com\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.claret-capital.com\/wp-json\/wp\/v2\/comments?post=3256"}],"version-history":[{"count":0,"href":"https:\/\/www.claret-capital.com\/wp-json\/wp\/v2\/posts\/3256\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.claret-capital.com\/wp-json\/wp\/v2\/media?parent=3256"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.claret-capital.com\/wp-json\/wp\/v2\/categories?post=3256"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}